---
figid: PMC4593375__40880_2015_7_Fig1_HTML
figlink: /pmc/articles/PMC4593375/figure/Fig1/
number: F1
caption: Schematic representation of the primary epidermal growth factor receptor
  (EGFR) signaling pathway. During normal EGFR signaling, receptor activation is dependent
  on ligand-mediated receptor dimerization. Once the subunits dimerize, a series of
  phosphorylation events serve to enhance EGFR kinase activity to stimulate the activation
  of downstream targets. Downstream signals are propagated by EGFR through three central
  pathways via both the direct phosphorylation of downstream targets (the JAK/STAT
  pathway) and the membrane recruitment of key adaptor proteins (the PI3K/AKT and
  MAPK pathways) to promote cell survival and proliferation. The EGFR signaling through
  a conserved core of three downstream signaling pathways demonstrates how the activation
  of this pathway via parallel RTKs, such as HER2, HER3, and MET, can circumvent the
  inhibitory effects of cetuximab and erlotinib on EGFR. EGFR, epidermal growth factor
  receptor; JAK/STAT, Janus activated kinase/signal transducer and activator of transcription;
  PI3K/AKT, phosphoinositide 3-kinase/protein kinase B; MAPK, mitogen-activated protein
  kinase; HER2, human epidermal growth factor receptor 2; HER3, human epidermal growth
  factor receptor 3; MET, hepatocyte growth factor receptor; SOS, son of sevenless;
  GRB2, growth factor receptor-bound protein 2; RAS, rat sarcoma family of proteins;
  RAF, rapidly accelerated fibrosarcoma; MEK, MAPK kinase; PTEN, phosphatase and tensin
  homolog; mTOR, mammalian target of rapamycin; FOXO, forkhead box proteins; NF-κB,
  nuclear factor-kappa B.
pmcid: PMC4593375
papertitle: 'Pharmacogenomics of EGFR-targeted therapies in non–small cell lung cancer:
  EGFR and beyond.'
reftext: Christopher Delaney, et al. Chin J Cancer. 2015;34:7.
pmc_ranked_result_index: '63166'
pathway_score: 0.9000977
filename: 40880_2015_7_Fig1_HTML.jpg
figtitle: The primary epidermal growth factor receptor (EGFR) signaling pathway
year: '2015'
organisms:
- Homo sapiens
ndex: 56d0b2ce-df10-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4593375__40880_2015_7_Fig1_HTML.html
  '@type': Dataset
  description: Schematic representation of the primary epidermal growth factor receptor
    (EGFR) signaling pathway. During normal EGFR signaling, receptor activation is
    dependent on ligand-mediated receptor dimerization. Once the subunits dimerize,
    a series of phosphorylation events serve to enhance EGFR kinase activity to stimulate
    the activation of downstream targets. Downstream signals are propagated by EGFR
    through three central pathways via both the direct phosphorylation of downstream
    targets (the JAK/STAT pathway) and the membrane recruitment of key adaptor proteins
    (the PI3K/AKT and MAPK pathways) to promote cell survival and proliferation. The
    EGFR signaling through a conserved core of three downstream signaling pathways
    demonstrates how the activation of this pathway via parallel RTKs, such as HER2,
    HER3, and MET, can circumvent the inhibitory effects of cetuximab and erlotinib
    on EGFR. EGFR, epidermal growth factor receptor; JAK/STAT, Janus activated kinase/signal
    transducer and activator of transcription; PI3K/AKT, phosphoinositide 3-kinase/protein
    kinase B; MAPK, mitogen-activated protein kinase; HER2, human epidermal growth
    factor receptor 2; HER3, human epidermal growth factor receptor 3; MET, hepatocyte
    growth factor receptor; SOS, son of sevenless; GRB2, growth factor receptor-bound
    protein 2; RAS, rat sarcoma family of proteins; RAF, rapidly accelerated fibrosarcoma;
    MEK, MAPK kinase; PTEN, phosphatase and tensin homolog; mTOR, mammalian target
    of rapamycin; FOXO, forkhead box proteins; NF-κB, nuclear factor-kappa B.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFKB1
  - JAK3
  - PIK3CB
  - PIK3R4
  - PIK3CA
  - STAT5B
  - SOS2
  - STAT4
  - STAT5A
  - MTOR
  - KRAS
  - NRAS
  - JAK2
  - AKT1
  - STAT3
  - PIK3CD
  - SOS1
  - PIK3R3
  - FOXO4
  - STAT6
  - PIK3CG
  - MET
  - BRAF
  - HRAS
  - TYK2
  - MAPK14
  - MAPK1
  - MAPK3
  - STAT1
  - STAT2
  - FOXO3
  - MAPK13
  - GRB2
  - JAK1
  - RAF1
  - MAP2K2
  - FOXO6
  - AKT2
  - PIK3R6
  - PIK3R5
  - MAPK11
  - PTEN
  - AKT3
  - EGFR
  - ARAF
  - MAPK9
  - ERBB2
  - MAP2K1
  - FOXO1
  - MAPK8
  - MAPK12
  - MAPK10
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4593375__F1
redirect_from: /figures/PMC4593375__F1
figtype: Figure
---
